Dapagliflozin & Teneligliptin

 Dapagliflozin & Teneligliptin
GLIDAPA TENE 5/20  
Dapagliflozin Sodium-glucose co-transporter 2 (SGLT2) inhibitor.Dapagliflozin works by inhibiting SGLT2 in the kidneys, reducing the reabsorption of glucose and increasing the excretion of glucose in the urine. It is used to improve glycemic control in adults with type 2 diabetes.Genital mycotic infections, urinary tract infections, increased urination, hypotension.
TeneligliptinDipeptidyl peptidase-4 (DPP-4) inhibitor.
Mechanism of Action: Teneligliptin inhibits the activity of DPP-4, an enzyme that breaks down incretin hormones. This leads to increased levels of incretins, which in turn enhances insulin release and reduces glucagon secretion.It is used to improve glycemic control in adults with type 2 diabetes.GLIDAPA TENE 10/20   is a common approach in the management of type 2 diabetes to achieve better blood sugar control.
Dapagliflozin and teneligliptin complement each other's actions, targeting different aspects of glucose metabolism.Steris Healthcare Pvt. Ltd. is a Leading Pharmaceutical Company in India. Established in the year of May 2018. We have 750+ Products & 16+ Super Specialty Segments. Every week we have a new product in our portfolio. In Last 4 nufacturers of India. Today we have 1000+ Business Franchise Partners in PAN India. Steris's medicine supply in India's Top or Reputed Hospitals, Pharmacy, Government use or Railway use. Grow with a similar pace with the STERIS. Be first to launch like us.
For further information please contact:
contact@sterispharma.com
Order now:
https://www.sterisonline.com/product/glidapa-tene-5-20-134232